Injectable Alginate Chitosan Hydrogel As a Promising Bioengineered Therapy for Acute Spinal Cord Injury Publisher Pubmed



Saadinam F^{1, 2} ; Azami M³ ; Pedram MS^{1, 2} ; Sadeghinezhad J⁴ ; Jabbari Fakhr M^{2, 5} ; Salimi A¹ ; Aminianfar H^{2, 6} ; Molazem M¹ ; Mokhber Dezfouli MR² ; Dehghan MM^{1, 2} Show Affiliations
Source: Scientific Reports Published:2024

Abstract

Dealing with spinal cord injuries presents problematic due to multiple secondary mechanisms. Beyond primary concerns like paralysis and disability, complications including urinary, gastrointestinal, cardiac, and respiratory disorders, along with substantial economic burdens may occur. Limited research focuses on modeling and treating contusion and compression injuries. Tissue engineering emerges as an innovative treatment, targeting lesion pathophysiology. This study was evaluated implanting injectable biomaterials into injury-induced cavity before glial scar formation, avoiding tissue incisions and minimizing further damage. The efficacy of injectable alginate/thiolated chitosan hydrogel was investigated for acute spinal cord injury induced by Vanicky method in Wistar rats. Three days post-injury, hydrogel was administrated through microinjection after laminectomy. After 60 days, the hydrogel group demonstrated notable motor function enhancement compared to the control by the BBB locomotor test (P < 0.05). However, no statistically significant differences were observed in MRI assessment concerning lesion severity. Stereological and histopathological evaluations revealed a reduction in vacuole volume and the presence of axon profiles within the scaffold (P < 0.05), alongside reduced infiltration of inflammatory and Gitter cells in the hydrogel group, although the latter was not statistically significant compared to the control. Thiolated chitosan/ alginate hydrogel implantation may be regarded as a promising treatment to enhance motor function by restraining destructive processes post-acute spinal cord injury. © The Author(s) 2024.